⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ZYME News
Zymeworks Inc.
Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform
globenewswire.com
ZYME
Zymeworks to Report First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026
globenewswire.com
ZYME
Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth
globenewswire.com
ZYME
Form 8-K
sec.gov
ZYME
Zymeworks Appoints Kristin Stafford as Chief Financial Officer
globenewswire.com
ZYME
Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate
globenewswire.com
ZYME
Zymeworks Announces Participation in Upcoming Investor Conferences
globenewswire.com
ZYME
Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting
globenewswire.com
ZYME
JAZZ
Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting
globenewswire.com
ZYME
Form 8-K
sec.gov
ZYME